Results for tag: "Impavido"

Impavido is a brand of infectious diseases drugs used to treat a variety of parasitic infections. It is a combination of miltefosine and albendazole, two active ingredients that work together to kill parasites. Impavido is used to treat leishmaniasis, a parasitic infection that affects millions of people worldwide. It is also used to treat other parasitic infections such as cutaneous and visceral leishmaniasis, as well as other diseases caused by parasites. Impavido is available in both oral and injectable forms, and is approved for use in many countries. The Impavido market is a rapidly growing sector of the infectious diseases drugs market. It is driven by the increasing prevalence of parasitic infections, as well as the need for more effective treatments. Companies in the Impavido market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Novartis. Show Less Read more